Covaxin approval soon? WHO chief scientist says Phase-3 trial data looks good
As Hyderabad-based pharma firm Bharat Biotech anticipates the World Health Organization’s endorsement for the crisis use posting for Covaxin, WHO Chief Scientist Soumya Swaminathan has said Covaxin’s Phase-3 information looks encouraging and the antibody can ideally be supported by the WHO by mid to late August. In a new meeting, Swaminathan said the Phase-3 preliminary … Read more